Operating Profit 更改
AbbVie USD 3.2B 914M 2023-12
Abbott USD 1.79B 119M 2023-12
ALKERMES USD 43.85M 195.34M 2023-09
Amgen USD 1.27B 819M 2023-12
AstraZeneca USD 1.95B 502M 2023-09
Biogen USD 358.9M 200.1M 2023-12
Bristol-Myers Squibb USD 1.85B 473M 2023-12
Catalent USD -112000000 614M 2023-12
Eli Lilly USD 2.39B 1.94B 2023-12
Gilead Sciences USD 1.61B 1.01B 2023-12
GlaxoSmithKline GBP 1.95B 192M 2023-09
J&J USD 4.83B 391M 2023-12
Merck USD -1933000000 7.68B 2023-12
Perrigo USD 62.1M 5.3M 2023-09
Pfizer USD -6551000000 3.61B 2023-12
Phibro Animal Health USD -726000 24.49M 2023-09
Prestige Brands USD 86.83M 1.42M 2023-12
Regeneron Pharmaceuticals USD 972.9M 138.1M 2023-12
Revance Therapeutics USD -139293000 73.79M 2023-09
Roche Holding CHF 9.76B 3.84B 2023-06
United Therapeutics USD 260.1M 66.9M 2023-12
Zoetis USD 650M 67M 2023-12



Bristol-Myers Squibb 营业利润 - 当前值,历史数据,预测,统计,图表和经济日历 - Mar 2024.